Delivery Order SPE2DB20D3111-SPE2DB25FA6JN

Award Date 1/24/25
Potential Completion Date 1/27/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Lidocaine 5% Patch 30s to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 5, 2025, with a completion date of February 6, 2025. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,969.60. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of Lidocaine 5% Patches to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 10, 2024 with a ceiling value of $20,466.17. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 11, 2024. There is no set-aside...
This federal contract award is for the delivery of Lidocaine 5% patches to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on July 3, 2024. The contract is a firm fixed-price delivery order with a ceiling value of $2,482.56 and a completion date of July 5, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award is for the delivery of Lidocaine 5% Patch 30s medical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 21, 2024, with a ceiling value of $2,666.94. The contract is a delivery order with a firm fixed price, and the ultimate completion date is May 22, 2024. This contract is not a set-aside award....
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Lidocaine 5% Patch 30s. The award, valued at $4,071.45, was made by the Defense Logistics Agency (DLA) on January 7, 2025, with a completion date of January 8, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of Lidocaine 5% Patches, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 28, 2024 with a ceiling value of $1,870.47 and a completion date of May 29, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of Lidocaine 5% Patch 30s, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 23, 2024 with a ceiling value of $11,303.00. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 24, 2024. This award is not designated with a set-aside. AmerisourceBergen holds a significant...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Lidocaine 5% Patch 30's, a pharmaceutical product, to the agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 26, 2023, with a ceiling value of $5,083.20 and a completion date of October 27, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation indicated for...
The federal contract award is for the delivery of Lidocaine 5% Patch, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 2, 2024, with a completion date of January 3, 2024 and a ceiling value of $17,683.23. This delivery order contract is awarded under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This federal contract award is for the delivery of Lidocaine 5% Patches (30 patches per box) to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 6, 2024. The contract has a firm fixed price and is a delivery order with a ceiling value of $1,185.84. The contract does not have a set-aside designation, indicating open competition. The award is associated...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB25FA6JN
    Delivery Order

This federal contract award is for the delivery of Lidocaine 5% Patch 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 24, 2025 with a ceiling value of $3,446.80. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 27, 2025. This contract award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/27/25, 12:42 AM